List of Tables (158 Tables)
Table 1 Public-Private Investments and Research Grants for the Development of HLA Typing Products, 2015–2018
Table 2 Cost of Assays for Major NGS/PCR-Based Genomic Tests in Europe (As of 2017)
Table 3 HLA Typing Market, By Product & Service, 2017–2025 (USD Million)
Table 4 Market for Reagents & Consumables, By Region, 2017–2025 (USD Million)
Table 5 Market for Instruments, By Region, 2017–2025 (USD Million)
Table 6 Market for Software & Services, By Region, 2017–2025 (USD Million)
Table 7 Market, By Technology, 2017–2025 (USD Million)
Table 8 Market for Molecular Assay Technologies, By Type, 2017–2025 (USD Million)
Table 9 Market for Molecular Assay Technologies, By Product & Service, 2017–2025 (USD Million)
Table 10 Market for Molecular Assay Technologies, By Application, 2017–2025 (USD Million)
Table 11 Market for Molecular Assay Technologies, By End User, 2017–2025 (USD Million)
Table 12 Market for Molecular Assay Technologies, By Region, 2017–2025 (USD Million)
Table 13 Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 14 Market for PCR-Based Molecular Assays, By Product & Service, 2017–2025 (USD Million)
Table 15 Market for PCR-Based Molecular Assays, By Application, 2017–2025 (USD Million)
Table 16 Market for PCR-Based Molecular Assays, By End User, 2017–2025 (USD Million)
Table 17 Market for PCR-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 18 Market for Sequence-Specific Primer-PCR, By Region, 2017–2025 (USD Million)
Table 19 Market for Sequence-Specific Oligonucleotide-PCR, By Region, 2017–2025 (USD Million)
Table 20 HLA Typing Market for Real-Time PCR, By Region, 2017–2025 (USD Million)
Table 21 Market for Other PCR-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 22 Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 23 Market for Sequencing-Based Molecular Assays, By Product & Service, 2017–2025 (USD Million)
Table 24 Market for Sequencing-Based Molecular Assays, By Application, 2017–2025 (USD Million)
Table 25 Market for Sequencing-Based Molecular Assays, By End User, 2017–2025 (USD Million)
Table 26 Market for Sequencing-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 27 Market for Sanger Sequencing, By Region, 2017–2025 (USD Million)
Table 28 Market for Next-Generation Sequencing, By Region, 2017–2025 (USD Million)
Table 29 Market for Other Sequencing-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 30 Market for Non-Molecular Assay Technologies, By Product & Service, 2017–2025 (USD Million)
Table 31 Market for Non-Molecular Assay Technologies, By Application, 2017–2025 (USD Million)
Table 32 HLA Typing Market for Non-Molecular Assay Technologies, By End User, 2017–2025 (USD Million)
Table 33 Market for Non-Molecular Assay Technologies, By Region, 2017–2025 (USD Million)
Table 34 Market, By Application, 2017–2025 (USD Million)
Table 35 Market for Diagnostic Applications, By Type, 2017–2025 (USD Million)
Table 36 HLA Typing Market for Diagnostic Applications, By Region, 2017–2025 (USD Million)
Table 37 Market for Donor-Recipient Cross-Matching, By Region, 2017–2025 (USD Million)
Table 38 Market for Infectious Disease Testing, By Region, 2017–2025 (USD Million)
Table 39 Market for Cancer Diagnosis & Prevention, By Region, 2017–2025 (USD Million)
Table 40 Market for Transfusion Therapy, By Region, 2017–2025 (USD Million)
Table 41 HLA Typing Market for Other Diagnostic Applications, By Region, 2017–2025 (USD Million)
Table 42 Market for Research Applications, By Region, 2017–2025 (USD Million)
Table 43 Market, By End User, 2017–2025 (USD Million)
Table 44 Market for Commercial Service Providers, By Region, 2017–2025 (USD Million)
Table 45 Market for Hospitals & Transplant Centers, By Region, 2017–2025 (USD Million)
Table 46 HLA Typing Market for Research Laboratories & Academic Institutes, By Region, 2017–2025 (USD Million)
Table 47 Market, By Region, 2017–2025 (USD Million)
Table 48 North America: Market, By Country, 2017–2025 (USD Million)
Table 49 North America: Market, By Technology, 2017–2025 (USD Million)
Table 50 North America: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 51 North America: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 52 North America: HLA Typing Market, By Product & Service, 2017–2025 (USD Million)
Table 53 North America: Market, By Application, 2017–2025 (USD Million)
Table 54 North America: Market, By End User, 2017–2025 (USD Million)
Table 55 Solid Organ Transplantations Performed in the US, 2017–2018
Table 56 Target Diseases in the US, 2018
Table 57 Cancer Cases in the US By Organ (New Cases), 2017
Table 58 US: Market, By Technology, 2017–2025 (USD Million)
Table 59 US: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 60 US: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 61 Solid Organ Transplantations Performed in Canada, 2017–2018
Table 62 Target Disease in Canada, 2017
Table 63 Cancer Cases in Canada By Organ (New Cases), 2018
Table 64 Canada: HLA Typing Market, By Technology, 2017–2025 (USD Million)
Table 65 Canada: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 66 Canada: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 67 Europe: Market, By Country, 2017–2025 (USD Million)
Table 68 Europe: Market, By Technology, 2017–2025 (USD Million)
Table 69 Europe: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 70 Europe: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 71 Europe: Market, By Product & Service, 2017–2025 (USD Million)
Table 72 Europe: Market, By Application, 2017–2025 (USD Million)
Table 73 Europe: Market, By End User, 2017–2025 (USD Million)
Table 74 Number of Organ Transplantations Performed in Germany, 2017–2018
Table 75 Target Disease in Germany, 2017
Table 76 Cancer Cases in Germany By Organ (New Cases), 2017
Table 77 Germany: HLA Typing Market, By Technology, 2017–2025 (USD Million)
Table 78 Germany: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 79 Germany: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 80 Number of Organ Transplantations Performed in the UK, 2017–2018
Table 81 Target Disease in the UK, 2017
Table 82 Cancer Cases in the UK By Organ (New Cases), 2018
Table 83 UK: Market, By Technology, 2017–2025 (USD Million)
Table 84 UK: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 85 UK: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 86 Number of Organ Transplantations Performed in France, 2017–2018
Table 87 Cancer Cases in France By Organ (New Cases), 2018
Table 88 France: HLA Typing Market, By Technology, 2017–2025 (USD Million)
Table 89 France: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 90 France: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 91 Italy: Market, By Technology, 2017–2025 (USD Million)
Table 92 Italy: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 93 Italy: HLA Typing Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 94 Spain: Market, By Technology, 2017–2025 (USD Million)
Table 95 Spain: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 96 Spain: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 97 RoE: Market, By Technology, 2017–2025 (USD Million)
Table 98 RoE: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 99 RoE: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 100 Asia Pacific: Market, By Country, 2017–2025 (USD Million)
Table 101 Asia Pacific: HLA Typing Market, By Technology, 2017–2025 (USD Million)
Table 102 Asia Pacific: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 103 Asia Pacific: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 104 Asia Pacific: Market, By Product & Service, 2017–2025 (USD Million)
Table 105 Asia Pacific: Market, By Application, 2017–2025 (USD Million)
Table 106 Asia Pacific: Market, By End User, 2017–2025 (USD Million)
Table 107 Number of Organ Transplantations Performed in China, 2017–2018
Table 108 Cancer Cases in China By Organ (New Cases), 2018
Table 109 China: Market, By Technology, 2017–2025 (USD Million)
Table 110 China: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 111 China: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 112 Number of Organ Transplantations Performed in India, 2017–2018
Table 113 Cancer Cases in India By Organ (New Cases), 2018
Table 114 India: Market, By Technology, 2017–2025 (USD Million)
Table 115 India: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 116 India: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 117 Number of Organ Transplantations Performed in Japan, 2017–2018
Table 118 Cancer Cases in Japan By Organ (New Cases), 2018
Table 119 Japan: Market, By Technology, 2017–2025 (USD Million)
Table 120 Japan: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 121 Japan: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 122 Number of Organ Transplantations Performed in Australia, 2017–2018
Table 123 Cancer Cases in Australia By Organ (New Cases), 2018
Table 124 Australia: Market, By Technology, 2017–2025 (USD Million)
Table 125 Australia: HLA Typing Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 126 Australia: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 127 South Korea: Market, By Technology, 2017–2025 (USD Million)
Table 128 South Korea: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 129 South Korea: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 130 RoAPAC: Market, By Technology, 2017–2025 (USD Million)
Table 131 RoAPAC: HLA Typing Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 132 RoAPAC: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 133 Latam: Market, By Country, 2017–2025 (USD Million)
Table 134 Latam: Market, By Technology, 2017–2025 (USD Million)
Table 135 Latam: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 136 Latam: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 137 Latam: Market, By Product & Service, 2017–2025 (USD Million)
Table 138 Latam: Market, By Application, 2017–2025 (USD Million)
Table 139 Latam: Market, By End User, 2017–2025 (USD Million)
Table 140 Solid Organ Transplantations Performed in the Brazil, 2017–2018
Table 141 Cancer Cases in Brazil By Organ (New Cases), 2018
Table 142 Brazil: Market, By Technology, 2017–2025 (USD Million)
Table 143 Brazil: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 144 Brazil: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 145 Solid Organ Transplantations Performed in Mexico, 2017–2018
Table 146 Cancer Cases in Mexico By Organ (New Cases), 2018
Table 147 Mexico: HLA Typing Market, By Technology, 2017–2025 (USD Million)
Table 148 Mexico: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 149 Mexico: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 150 RoLAtam: Market, By Technology, 2017–2025 (USD Million)
Table 151 RoLAtam: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 152 RoLAtam: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 153 MEA: Market, By Technology, 2017–2025 (USD Million)
Table 154 MEA: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 155 MEA: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 156 MEA: Market, By Product & Service, 2017–2025 (USD Million)
Table 157 MEA: Market, By Application, 2017–2025 (USD Million)
Table 158 MEA: HLA Typing Market, By End User, 2017–2025 (USD Million)